股票收益分析

Search documents
Johnson & Johnson: Buy JNJ Stock Ahead of Its Upcoming Earnings?
Forbes· 2025-07-14 14:05
Core Insights - Johnson & Johnson (NYSE: JNJ) is expected to report earnings of $2.68 per share and sales of $22.86 billion on July 16, 2025, compared to $2.82 per share and $22.45 billion in the same quarter last year [3] - The company has a market capitalization of $378 billion and reported $89 billion in revenue over the past twelve months, with $22 billion in operating profits and $22 billion in net income [4] Historical Performance - Historically, JNJ has delivered positive one-day returns in 55% of cases following earnings announcements over the past five years, with a median positive return of 2.3% and a peak one-day positive return of 6.1% [2][7] - Over the last five years, there have been 20 recorded earnings data points, with 11 resulting in positive and 9 in negative one-day returns [7] - The percentage of positive one-day returns drops to 33% when analyzing data from the last three years [7] Trading Strategies - Traders may consider taking a position prior to the earnings release based on historical data or wait for the earnings to be disclosed to analyze immediate and medium-term returns [6] - A correlation analysis between short-term and medium-term returns can guide trading choices, particularly if 1D and 5D returns demonstrate a strong correlation [8]